Y H Lee1, S-C Bae, J-H Kim, Y H Seo, S J Choi, J D Ji, G G Song. 1. Division of Rheumatology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, 126-1, Anam-dong 5-ga, Seongbuk-gu, 136-705, Seoul, Korea, lyhcgh@korea.ac.kr.
Abstract
OBJECTIVE: The aim in this study was to determine whether solute carrier family 22, member 4 (SLC22A4), and runt-related transcription factor 1 (RUNX1) polymorphisms are associated with susceptibility to rheumatoid arthritis (RA) in populations of different ethnicities. METHODS: We conducted a literature search using the MEDLINE and EMBASE, and performed a meta-analysis using a fixed or random effects model. RESULTS: A total of 26 comparative studies from 14 articles met the study inclusion criteria. Studies on the SLC22A4 polymorphism involved 12,458 RA patients and 9283 controls, and studies on the RUNX1 polymorphism involved 3958 RA patients and 3773 controls. The meta-analysis showed no association between the 22 + 21 genotype of the SLC22A4 F1 and RA in overall group [odds ratio (OR) 1.074, 95 % confidence interval (CI) 0.952-1.212, p = 0.245]. After stratification by ethnicity, the meta-analysis indicated that the 22 + 21 genotype of the SLC22A4 F1 was associated significantly with RA in the East Asian population, but not in the European population (OR 1.124, 95 % CI 1.018-1.240, p = 0.021; OR 0.981, 95 % CI 0.773-1.243, p = 0.871). CONCLUSION: This meta-analysis demonstrates that the SLC22A4 F1 polymorphism is associated with susceptibility to RA in East Asians, but not in Europeans.
OBJECTIVE: The aim in this study was to determine whether solute carrier family 22, member 4 (SLC22A4), and runt-related transcription factor 1 (RUNX1) polymorphisms are associated with susceptibility to rheumatoid arthritis (RA) in populations of different ethnicities. METHODS: We conducted a literature search using the MEDLINE and EMBASE, and performed a meta-analysis using a fixed or random effects model. RESULTS: A total of 26 comparative studies from 14 articles met the study inclusion criteria. Studies on the SLC22A4 polymorphism involved 12,458 RApatients and 9283 controls, and studies on the RUNX1 polymorphism involved 3958 RApatients and 3773 controls. The meta-analysis showed no association between the 22 + 21 genotype of the SLC22A4 F1 and RA in overall group [odds ratio (OR) 1.074, 95 % confidence interval (CI) 0.952-1.212, p = 0.245]. After stratification by ethnicity, the meta-analysis indicated that the 22 + 21 genotype of the SLC22A4 F1 was associated significantly with RA in the East Asian population, but not in the European population (OR 1.124, 95 % CI 1.018-1.240, p = 0.021; OR 0.981, 95 % CI 0.773-1.243, p = 0.871). CONCLUSION: This meta-analysis demonstrates that the SLC22A4 F1 polymorphism is associated with susceptibility to RA in East Asians, but not in Europeans.
Authors: D Plant; A Barton; W Thomson; X Ke; S Eyre; A Hinks; J Bowes; L J Gibbons; A G Wilson; I Marinou; A W Morgan; S Steer; L J Hocking; D M Reid; P Wordsworth; P Harrison; J Worthington Journal: Ann Rheum Dis Date: 2009-08 Impact factor: 19.103
Authors: Gisela Orozco; Elena Sánchez; Miguel A González-Gay; Miguel A López-Nevot; Belén Torres; Dora Pascual-Salcedo; Alejandro Balsa; Jose L Pablos; Antonio García; Maria Francisca González-Escribano; Javier Martín Journal: J Rheumatol Date: 2006-07 Impact factor: 4.666
Authors: Robert M Plenge; Leonid Padyukov; Elaine F Remmers; Shaun Purcell; Annette T Lee; Elizabeth W Karlson; Frederick Wolfe; Daniel L Kastner; Lars Alfredsson; David Altshuler; Peter K Gregersen; Lars Klareskog; John D Rioux Journal: Am J Hum Genet Date: 2005-11-01 Impact factor: 11.025
Authors: K Komlósi; G C Talián; B Faragó; L Magyari; V Cserép; B Kovács; J Bene; V Havasi; C G Kiss; L Czirják; B Melegh Journal: Clin Exp Rheumatol Date: 2008 Jan-Feb Impact factor: 4.473
Authors: Irina Borodina; Louise C Kenny; Cathal M McCarthy; Kalaivani Paramasivan; Etheresia Pretorius; Timothy J Roberts; Steven A van der Hoek; Douglas B Kell Journal: Nutr Res Rev Date: 2020-02-13 Impact factor: 7.800